Cargando…
Deep Vein Thrombosis after COVID-19 Vaccinations
Background: COVID-19 vaccinations in the United States (Janssen, Moderna, and Pfizer) have been deemed generally safe and effective. Rare thrombotic events, now termed vaccine-induced thrombotic thrombocytopenia (VITT), have been reported after the Janssen and Moderna vaccinations. With millions of...
Autores principales: | Houghton, Damon E., Padmanabhan, Anand, Ashrani, Aneel A., Wysokinska, Ewa, Chaudhary, Rahul, Padrnos, Leslie, Pruthi, Rajiv K., Sridharan, Meera, Shah, Surbhi, Wysokinski, Waldemar E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701576/ http://dx.doi.org/10.1182/blood-2021-151396 |
Ejemplares similares
-
An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy
por: Kaufman, Adrienne, et al.
Publicado: (2021) -
Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19
por: Pasha, Ahmed K., et al.
Publicado: (2021) -
No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2022) -
Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis
por: Madeeva, Daria V, et al.
Publicado: (2021) -
Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19–Positive Compared With COVID-19–Negative Patients
por: Chaudhary, Rahul, et al.
Publicado: (2021)